Live feed
Filing
SC 13G
SC 13G0001193125-15-234989·Oruka Therapeutics, Inc.
Schedule 13G ownership disclosure
ARCA biopharma, Inc.
Security class unavailable · CUSIP: 00211Y100
Event date: 2015-06-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-234989
- Form type
- SC 13G
- Filer
- Oruka Therapeutics, Inc.
- CIK
- CIK 907654
- Filed
- Jun 25, 2015
- Reporting period
- Jun 16, 2015
- Description
- Schedule 13G beneficial ownership